摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Gancaonin H | 126716-35-6

中文名称
——
中文别名
——
英文名称
Gancaonin H
英文别名
5,7-dihydroxy-3-(8-hydroxy-2,2-dimethylchromen-6-yl)-6-(3-methylbut-2-enyl)chromen-4-one
Gancaonin H化学式
CAS
126716-35-6
化学式
C25H24O6
mdl
——
分子量
420.5
InChiKey
CCUZOQMNQONIMX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    31
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    96.2
  • 氢给体数:
    3
  • 氢受体数:
    6

文献信息

  • [EN] PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS<br/>[FR] PROCÉDÉS DE PRÉPARATION DE COMPOSÉS HYDROXY-ARYLE ORTHO-ALLYLÉS
    申请人:UNIV MCMASTER
    公开号:WO2021237371A1
    公开(公告)日:2021-12-02
    The present application describes process for preparing an ortho-allylated hydroxy aryl compounds such as compounds of Formula (I) by reacting an allylic alcohol with a hydroxy aryl compound in the presence of aluminum compound selected from alumina and aluminum alkoxides and in a non-protic solvent wherein at least one carbon atom ortho to the hydroxy group in the hydroxy aryl compound is unsubstituted. The present application also includes compounds of Formula (I).
    本申请描述了一种制备邻烯丙基羟基芳基化合物的方法,例如通过在非质子溶剂中,在氧化铝和铝烷氧化物中选择的铝化合物存在下,将烯丙醇与羟基芳基化合物反应,其中羟基芳基化合物中至少有一个碳原子位于羟基的邻位且未被取代。本申请还包括化合物的化学式(I)。
  • PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGANDS AND PROCESS FOR PRODUCING THE SAME
    申请人:KANEKA CORPORATION
    公开号:EP1440688A1
    公开(公告)日:2004-07-28
    The present invention easily and efficiently provides a peroxisome proliferator-activated receptor ligand, and a composition for amelioration of insulin resistance or for prevention and/or amelioration of the insulin resistance syndrome containing the same, as an active ingredient. The present invention relates to a peroxisome proliferator-activated receptor ligand which comprises a prenylflavonoid, a chalcone derivative exclusive of prenylflavonoids, a flavonol derivative exclusive of prenylflavonoids, and a salt, a glycoside and/or an esterified substance thereof acceptable as a pharmaceutical preparation or a food or a beverage; a composition containing the above ligand; a plant-derived extract containing the above ligand; and a process for producing the above extract.
    本发明简便高效地提供了一种过氧化物酶体增殖体激活受体配体,以及一种用于改善胰岛素抵抗或预防和/或改善胰岛素抵抗综合征的组合物,其中含有该配体作为活性成分。 本发明涉及一种过氧化物酶体增殖体激活受体配体,它包括一种前黄酮类化合物、一种不包括前黄酮类化合物的查尔酮衍生物、一种不包括前黄酮类化合物的黄酮醇衍生物,以及可作为药物制剂或食品或饮料的盐、苷和/或酯化物质;一种含有上述配体的组合物;一种含有上述配体的植物提取物;以及一种生产上述提取物的工艺。
  • Peroxisome proliferator activated receptor ligands and process for producing the same
    申请人:Mae Tatsumasa
    公开号:US20050014819A1
    公开(公告)日:2005-01-20
    The present invention easily and efficiently provides a peroxisome proliferator-activated receptor ligand, and a composition for amelioration of insulin resistance or for prevention and/or amelioration of the insulin resistance syndrome containing the same, as an active ingredient. The present invention relates to a peroxisome proliferator-activated receptor ligand which comprises a prenylflavonoid, a chalcone derivative exclusive of prenyl flavonoids, a flavonol derivative exclusive of prenylflavonoids, and a salt, a glycoside and/or an esterified substance thereof acceptable as a pharmaceutical preparation or a food or a beverage; a composition containing the above ligand; a plant-derived extract containing the above ligand; and a process for producing the above extract.
    本发明简便高效地提供了一种过氧化物酶体增殖体激活受体配体,以及一种用于改善胰岛素抵抗或预防和/或改善胰岛素抵抗综合征的组合物,其中含有该配体作为活性成分。本发明涉及一种过氧化物酶体增殖体激活受体配体,它包括一种前酰基类黄酮、一种不包括前酰基类黄酮的查尔酮衍生物、一种不包括前酰基类黄酮的黄酮醇衍生物,以及可作为药物制剂或食品或饮料的盐、苷和/或酯化物质;一种含有上述配体的组合物;一种含有上述配体的植物提取物;以及一种生产上述提取物的工艺。
  • PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGAND AND PROCESS FOR PRODUCING THE SAME
    申请人:MAE Tatsumasa
    公开号:US20090036519A1
    公开(公告)日:2009-02-05
    The present invention easily and efficiently provides a peroxisome proliferator-activated receptor ligand, and a composition for amelioration of insulin resistance or for prevention and/or amelioration of the insulin resistance syndrome containing the same, as an active ingredient. The present invention relates to a peroxisome proliferator-activated receptor ligand which comprises a prenylflavonoid, a chalcone derivative exclusive of prenylflavonoids, a flavonol derivative exclusive of prenylflavonoids, and a salt, a glycoside and/or an esterified substance thereof acceptable as a pharmaceutical preparation or a food or a beverage; a composition containing the above ligand; a plant-derived extract containing the above ligand; and a process for producing the above extract.
  • PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS
    申请人:McMaster University
    公开号:US20210380513A1
    公开(公告)日:2021-12-09
    The present application describes process for preparing an ortho-allylated hydroxy aryl compounds such as compounds of Formula (I) by reacting an allylic alcohol with a hydroxy aryl compound in the presence of aluminum compound selected from alumina and aluminum alkoxides and in a non-protic solvent wherein at least one carbon atom ortho to the hydroxy group in the hydroxy aryl compound is unsubstituted. The present application also includes compounds of Formula (I).
查看更多